期刊文献+

MACC1蛋白在肝细胞癌中的表达水平及其与患者预后的关系 被引量:4

Expression of MACC1 Protein in Hepatocellular Carcinoma and Its Relationship with the Prognosis of Patients
下载PDF
导出
摘要 目的探讨MACC1(metastasis-associated in colon cancer-1)蛋白在肝细胞癌中的表达水平及其与患者预后之间的关系。方法免疫组化法检测MACC1蛋白在30例不同恶性程度的肝细胞癌中细胞分布特点;Western blot检测70例肝癌及其相对应的癌旁肝组织,30例正常肝组织中的MACC1蛋白的表达水平;随访分析不同患者的预后转归。结果免疫组化检测MACC1蛋白在肝细胞肝癌中阳性表达率为93.3%(28/30),Edmonson病理分级Ⅰ+Ⅱ和Ⅲ+Ⅳ级肝癌组织中MACC1核阳性表达率分别为26.3%、77.8%(5/19、7/9,P=0.031)。MACC1蛋白在肝癌组织、癌旁组织和正常肝组织中的相对灰度值分别为(1.33±1.17)、(0.59±0.57)、(0.003±0.001)(P=0.034)。高表达MACC1蛋白组和低表达组术后3年生存率分别为43.35%、73.45%(P=0.017)。结论 MACC1蛋白的表达异常与患者预后密切相关,联合检测MACC1蛋白的表达水平,对于指导临床治疗具有重要意义。 Objective To explore the expression of metastasis-associated in colon cancer-1(MACC1)protein in hepatocellular carcinoma(HCC)and its relationship with the prognosis of patients.Methods The expression of MACC1protein was immunohistochemically detected in 30cases of HCC with different degree of malignancy.The expression levels of MACC1protein in 70HCC tissues and their adjacent nontumorous liver tissues,and 30normal liver tissues were measured by Western blot.The patients were followed up and their prognosis was analyzed.Results Immunohistochemical staining showed that the positive expression rate of MACC1protein in HCC was 93.3%(28/30).The nuclear positive rate of MACC1protein was 26.3%and 77.8%in HCC with Edmonson gradesⅠ+ⅡandⅢ+Ⅳ,respectively(5/19,7/9;P=0.031).The relative gray value of MACC1protein was(1.33±1.17),(0.59±0.57),(0.003±0.001)in HCC tissues,adjacent nontumorous liver tissues and normal liver tissues,respectively(P=0.034).The 3-year survival rate was 43.35%and 73.45%in high MACC1expression group and low MACC1expression group,respectively(P=0.017).Conclusion The abnormal expression of MACC1 protein is closely related to the prognosis of HCC patients.Combined detection for the expression of MACC1protein,along with other relevant factors,is of great importance to guide clinical treatment.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2013年第4期464-468,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.81071897)
关键词 肝细胞癌 MACC1蛋白 预后 hepatocellular carcinoma metastasis-associated in colon cancer-1(MACC1) prognosis
  • 相关文献

参考文献19

  • 1Parkin D M,Bray F,Ferlay J,et al.Estimating the world cancer burden:Globocan 2000[J].Int J Cancer,2001,94(2):153-156.
  • 2Stein U,Walther W,Arlt F,et al.MACC1,a newly identified key regulator of HGF-MET signaling,predicts colon cancer metastasis[J].Nat Med,2009,15(1):59-67.
  • 3刘清泉,刘青光,昝献峰,郭成,宋涛,姚英民.MACC1基因在肝细胞癌中的表达及临床意义[J].华中科技大学学报(医学版),2010,39(1):22-24. 被引量:19
  • 4尚超,张辉,宋永胜.MACC1基因与肾癌转移的相关性及其对细胞侵袭能力的影响[J].现代肿瘤医学,2011,19(4):637-639. 被引量:8
  • 5杨淑慧,龙敏,王希,林芳,张惠中.MACC1基因siRNA对肺癌SBC-5细胞增殖和迁移的影响[J].现代肿瘤医学,2011,19(4):633-636. 被引量:10
  • 6O′connell J B,Maggard M A,Liu J H,et al.A report card on outcomes for surgically treated gastrointestinal cancers:are we improving?[J].J Surg Res,2004,121(2):214-221.
  • 7Yang L Y,Fang F,Ou D P,et al.Solitary large hepatocellular carcinoma:a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection[J].Ann Surg,2009,249(1):118-123.
  • 8Cherqui D,Laurent A,Mocellin N,et al.Liver resection for transplantable hepatocellular carcinoma:long-term survival and role of secondary liver transplantation[J].Ann Surg,2009,250(5):738-746.
  • 9Ma P C,Maulik G,Christensen J,et al.c-Met:structure,functions and potential for therapeutic inhibition[J].Cancer Metastasis Rev,2003,22(4):309-325.
  • 10Forte G,Minieri M,Cossa P,et al.Hepatocyte growth factor effects on mesenchymal stem cells:proliferation,migration,and differentiation[J].Stem Cells,2006,24(1):23-33.

二级参考文献51

  • 1Jian-PingLu,JianWang,TaoWang,YiWang,wei-Qingwu,LiGao.Microvessel density of malignant and benign hepatic lesions and MRI evaluation[J].World Journal of Gastroenterology,2004,10(12):1730-1734. 被引量:13
  • 2Stein U, Walther W, Arlt F, et al. Maccl, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis[J]. Nat Med,2009,15(1):59- 67.
  • 3Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more[J]. Nat Rev Mol Cell Biol, 2003,4 (12) : 915-925.
  • 4Wang R,Ferrell L D,Faouzi S,et al. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice[J]. Cell Biol, 2001,153 (5) 1023-1034.
  • 5Bell A,Chen Q,Defrances M C,et al. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice [J ]. Oneogene, 1999,18 ( 4 ) : 887- 895.
  • 6Neaud V, Faouzi S, Guirouilh J, et al. Human hepatic myofibrob lasts increase invasiveres of hepatocellular carcinoma cells:evidence for a role of hepatocyte growth factor [J]. Hepatology, 1997,26(6) : 1458-1466.
  • 7Ueki T, Fujimoto J, Suzuki T, et al. Expression of hepatocyte growth factor and its receptor c- met proto-oncogene in hepatocellular carcinoma[J]. Hepatology, 1997,25 (4) : 862-866.
  • 8O'connell J B,Maggard M A,Liu j H,et al. A report card on outcomes for surgically treated gastrointestinal cancers: are we improving? [J].J Surg Res,2004,121(2):214-221.
  • 9Danilkovitch-Miagkova A, Zbar B. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors [J].J Clin Invest,2002,109(7) :863- 867.
  • 10Stefan M, Koch A, Mancini A, et al. Src homology 2 -containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c -Met and potentiates hepatocyte growth factor-0induced branching tubulogenesis[J]. J Biol Chem, 2001, 276(5) :3017- 3023.

共引文献44

同被引文献27

  • 1翟仁友,王剑锋,戴定可,于平,魏宝杰.肝癌合并梗阻性黄疸的介入治疗[J].中国介入影像与治疗学,2006,3(2):81-83. 被引量:18
  • 2李桂源,刘华英,周鸣,周后德,李小玲.鼻咽癌癌变的分子机理[J].生物化学与生物物理进展,2006,33(10):922-931. 被引量:33
  • 3胡德杨.肝血管瘤介入治疗后胆囊坏死穿孔及反复胆道出血和胆管狭窄闭锁1例教训分析[J].腹部外科,1996,9(3):140-140. 被引量:2
  • 4Miyayama S, Yamashiro M, Okuda M, et al. Main bile duct stricture occurring after transcatheter arterial chemoemboli- zation for hepatocellular carcinoma[J]. Cardiovasc Intervent Radiol,2010,33(6) :1168-1179.
  • 5Bang B W, Lee D H,Jeong S, et al. Ischemic biliary stricture developed after repeated transeatheter arterial chemoemboli- zation diagnosed by percutaneous transhepatic cholangioscopy in a patient with hepatoeellular carcinoma[J]. Gastrointest Endos,2008,68(6):1224-1226.
  • 6Caturelli E, Siena D A, Fusilli S, et al. Transcatheter arterial ehemoembolization for hepatoeellular carcinoma in patients with cirrhosis:evaluation of damage to nontumorous liver tis- sue long term prospective study[J]. Radiology, 2000,215 ( 1 ) : 123-128.
  • 7Choi J Y,Lee J M,Lee J Y,et al. Navigator-triggered isotropic three-dimensional magnetic resonance eholangiopancreatog raphy in the diagnosis of malignant biliary obstructions:corn parison with direct cholangiography[J]. JMRI, 2008,27 ( 1 ) 94-101.
  • 8Kim J Y, Lee J M, Han J K, et al. Contrast-enhanced MRI combined with MR cholangiopancreatography for the evalua- tion of patients with biliary strictures, differentiation of ma- lignant from benign bile duct strictures[J]. JMRI, 2007, 26 (2) :304-312.
  • 9张文玲,周艳宏,肖岚,范松青,曾朝阳,李小玲,武明花,李桂源.鼻咽癌分子标志物研究[J].生物化学与生物物理进展,2008,35(1):7-13. 被引量:32
  • 10张政,李敏,覃颖,韦海明,丁志敏,司勇锋,陆锦龙,李冰,何承诚.鼻咽癌远处转移49例病理分析[J].广西医学,2008,30(11):1681-1682. 被引量:3

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部